Matt Zabel - Biotricity Vice Strategy
Executive
Matt Zabel is Vice Strategy of Biotricity
| Phone | (800) 590-4155 |
| Web | https://www.biotricity.com |
Matt Zabel Latest Insider Activity
Tracking and analyzing the buying and selling activities of Matt Zabel against Biotricity stock is an integral part of due diligence when investing in Biotricity. Matt Zabel insider activity provides valuable insight into whether Biotricity is net buyers or sellers over its current business cycle. Note, Biotricity insiders must abide by specific rules, including filing SEC forms every time they buy or sell Biotricity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Matt Zabel over a year ago Sale by Matt Zabel of 4000 shares of Target | ||
Matt Zabel over a year ago Acquisition by Matt Zabel of 870 shares of Target subject to Rule 16b-3 | ||
Matt Zabel over a year ago Target exotic insider transaction detected |
Biotricity Management Efficiency
The company has return on total asset (ROA) of (0.8862) % which means that it has lost $0.8862 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.0079) %, meaning that it created substantial loss on money invested by shareholders. Biotricity's management efficiency ratios could be used to measure how well Biotricity manages its routine affairs as well as how well it operates its assets and liabilities.Biotricity currently holds 23.88 M in liabilities with Debt to Equity (D/E) ratio of 6.45, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biotricity has a current ratio of 1.51, which is within standard range for the sector. Note, when we think about Biotricity's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ronald CPA | MaxCyte | 67 | |
| Jennifer Englund | CVRx Inc | N/A | |
| Andrew Cormack | enVVeno Medical Corp | N/A | |
| Martha Rook | Delcath Systems | 55 | |
| Michael Parks | PAVmed Inc | N/A | |
| CPA CFA | MaxCyte | 56 | |
| MD MSc | Delcath Systems | 57 | |
| Monica Hamling | Nortech Systems Incorporated | N/A | |
| Gordon Weber | SurModics | 61 | |
| Gordon JD | SurModics | 62 | |
| Jay Gelfman | MaxCyte | N/A | |
| Tim Benner | Inari Medical | N/A | |
| Ellisa Cholapranee | Clearpoint Neuro | N/A | |
| Hamed Alavi | enVVeno Medical Corp | 42 | |
| John Lindeen | Nortech Systems Incorporated | 60 | |
| Michael Fleming | BioSig Technologies, Common | 50 | |
| Sarah Meeks | MaxCyte | N/A | |
| Gregory Firestone | Tela Bio | 66 | |
| Lawrence Lin | Ainos Inc | 55 | |
| Victoria Lee | PAVmed Inc | N/A | |
| David Hoffman | Delcath Systems | N/A | |
Management Performance
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 |
Biotricity Leadership Team
Elected by the shareholders, the Biotricity's board of directors comprises two types of representatives: Biotricity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotricity. The board's role is to monitor Biotricity's management team and ensure that shareholders' interests are well served. Biotricity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotricity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fareeha Siddiqui, Senior Solutions | ||
| Amjad Talpur, Senior Operations | ||
| George Nikopoulos, Director Development | ||
| Waqaas AlSiddiq, Founder, Chairman, CEO and Executive Officer | ||
| Amir Ali, Chief Officer | ||
| John Ayanoglou, Chief Officer | ||
| Andy Wong, Vice Operations | ||
| Matt Zabel, Vice Strategy |
Biotricity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biotricity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 38.87 M | ||||
| Shares Outstanding | 21.48 M | ||||
| Shares Owned By Insiders | 48.61 % | ||||
| Shares Owned By Institutions | 1.62 % | ||||
| Number Of Shares Shorted | 459.95 K | ||||
| Price To Earning | (6.70) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Biotricity Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |